Quick Answer
ABEONA THERAPEUTICS INC. reported Net Income Loss of $71.18 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed an increase of +211.7% in Net Income Loss from 2024 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ABEONA THERAPEUTICS INC.'s Net Income Loss has grown by 1,044.4%.
- Historical annual values: Fiscal year 2025: $71.18 million | Fiscal year 2024: -$63.73 million | Fiscal year 2023: -$54.19 million | Fiscal year 2022: -$39.70 million | Fiscal year 2021: -$84.94 million | Fiscal year 2020: -$84.23 million | Fiscal year 2019: -$76.28 million | Fiscal year 2018: -$56.67 million | Fiscal year 2017: -$27.32 million | Fiscal year 2016: -$21.87 million | Fiscal year 2015: -$14.53 million | Fiscal year 2014: -$26.78 million | Fiscal year 2013: $4.45 million | Fiscal year 2012: -$10.53 million | Fiscal year 2011: -$2.53 million | Fiscal year 2010: -$7.54 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: